We've found
45,497
archived clinical trials in
Breast Cancer
We've found
45,497
archived clinical trials in
Breast Cancer
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Updated: 7/4/2015
Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Citalopram in Treating Postmenopausal Women With Hot Flashes
Updated: 7/4/2015
Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes
Status: Enrolling
Updated: 7/4/2015
Click here to add this to my saved trials